FuelCell Energy Inc vs 22nd Century Group Inc — how do they compare? FuelCell Energy Inc trades at $18.44 (market cap $1.62B), while 22nd Century Group Inc trades at $4.27 (market cap $1.52M). The key difference: FuelCell Energy Inc is far larger — about 1065.8× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| FCEL | XXII | |
|---|---|---|
Market Cap | $1.62B | $1.52M |
Sector | Industrials | Technology |
52-Week High | $36.01 | $1.47K |
52-Week Low | $3.92 | $3.90 |
Enterprise Value | $1.47B | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
FuelCell Energy (FCEL) trades at $21.35, up 11.9% in the last 24 hours, reflecting high volatility amid recent news. The stock shows a neutral technical signal with bearish moving averages, while fundamentals reveal persistent losses with a net income margin of -132.41% in 2025 despite revenue growth to $158.16M. Recent developments include a strategic partnership with Siemens to scale clean power solutions and a $225M stock offering that caused temporary dilution concerns.
The outlook is mixed: analyst consensus is balanced with a $20.75 price target, but continued cash burn and high valuation multiples pose risks. Opportunities lie in AI-driven data center demand, though profitability remains a key challenge for sustainable upside.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products, which efficiently convert chemical energy in fuels into electricity through a series of chemical reactions. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.
Read more on FCEL →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →